EA200400427A1 - Применение человеческого хорионического гонадотропина и лютеинизирующего гормона при контролируемой гиперстимуляции яичников - Google Patents
Применение человеческого хорионического гонадотропина и лютеинизирующего гормона при контролируемой гиперстимуляции яичниковInfo
- Publication number
- EA200400427A1 EA200400427A1 EA200400427A EA200400427A EA200400427A1 EA 200400427 A1 EA200400427 A1 EA 200400427A1 EA 200400427 A EA200400427 A EA 200400427A EA 200400427 A EA200400427 A EA 200400427A EA 200400427 A1 EA200400427 A1 EA 200400427A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- lutinesising
- horionic
- gonadotropin
- human
- application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Изобретение предоставляет последовательность операций, ведущую к увеличению частоты имплантации эмбриона и/или снижению частоты выкидышей, причем чХГ или его биологический аналог вводят в течение фолликулярной фазы.Отчет о международном поиске был опубликован 2003.12.18.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01307757 | 2001-09-12 | ||
PCT/GB2002/004158 WO2003022302A2 (en) | 2001-09-12 | 2002-09-12 | USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200400427A1 true EA200400427A1 (ru) | 2004-08-26 |
EA009330B1 EA009330B1 (ru) | 2007-12-28 |
Family
ID=8182261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200400427A EA009330B1 (ru) | 2001-09-12 | 2002-09-12 | Способ содействия имплантации и/или снижения частоты выкидышей и набор для его осуществления |
Country Status (20)
Country | Link |
---|---|
US (1) | US7405197B2 (ru) |
EP (1) | EP1425032A2 (ru) |
JP (1) | JP2005501918A (ru) |
KR (1) | KR20040032954A (ru) |
CN (1) | CN100536912C (ru) |
AR (1) | AR036592A1 (ru) |
BR (1) | BR0212429A (ru) |
CA (1) | CA2457849A1 (ru) |
EA (1) | EA009330B1 (ru) |
HK (1) | HK1067867A1 (ru) |
HR (1) | HRP20040087A2 (ru) |
IL (1) | IL160780A0 (ru) |
ME (1) | MEP39208A (ru) |
MX (1) | MXPA04002256A (ru) |
NO (1) | NO20040991L (ru) |
PL (1) | PL369098A1 (ru) |
RS (1) | RS21004A (ru) |
UA (1) | UA82650C2 (ru) |
WO (1) | WO2003022302A2 (ru) |
ZA (1) | ZA200400835B (ru) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060258568A1 (en) * | 2003-02-07 | 2006-11-16 | Austia Wirtschaftsservice Gesellschaft Mit Beschrankter | Use of human chorionic gonadotropin in the treatment in the treatment of symptoms endometriosis |
US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
US20150273020A1 (en) * | 2007-05-11 | 2015-10-01 | Lori R. Bernstein | Hormone Normalization Therapy and Uses Therefor |
EP2243423B1 (de) * | 2009-04-23 | 2012-05-02 | Roche Diagnostics GmbH | Verfahren und Gerät zur Ermittlung von Empfehlungen für Wirkstoffdosierungen anhand von Messserien zumindest eines physiologischen Parameters eines Patienten |
TWI532495B (zh) | 2009-10-05 | 2016-05-11 | 菲瑞茵國際中心股份有限公司 | 藥學製劑 |
CA3163525A1 (en) | 2011-03-31 | 2012-10-04 | Ferring Bv. | Pharmaceutical preparation |
US20120265129A1 (en) | 2011-04-15 | 2012-10-18 | Neuralight Hd, Llc | Methods for Chronic Pain Management and Treatment using HCG |
US8680086B2 (en) | 2011-04-15 | 2014-03-25 | Neuralight Hd, Llc | Methods for chronic pain management and treatment using HCG |
KR20140053991A (ko) * | 2011-07-18 | 2014-05-08 | 아츠 바이올로직스 에이/에스 | 장기간 작용하는 황체 형성 호르몬 (lh) 화합물 |
US10271876B2 (en) | 2011-11-23 | 2019-04-30 | Mezadata Medical Ip Holding Llc | Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells |
MX2015004940A (es) | 2012-10-18 | 2015-12-09 | Neuralight Hd Llc | Tratamiento de depresion y ptsd. |
WO2014159813A1 (en) | 2013-03-13 | 2014-10-02 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
MX2019000498A (es) | 2016-07-21 | 2019-09-16 | ObsEva SA | Regímenes de dosis de antagonista de oxitocina para promover la implantación embrionaria y prevenir abortos espontaneos. |
CA3035055A1 (en) | 2016-08-29 | 2018-03-08 | Progena, Inc. | Autologous somatic stem cell therapy, method of controllable preparation of therapeutic composition and procedure of adaptive treatment of ivf patient |
RU2646578C1 (ru) * | 2017-02-13 | 2018-03-05 | Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) | Способ повышения эффективности имплантации эмбриона в естественном цикле зачатия и в протоколах вспомогательных репродуктивных технологий |
CN109431647B (zh) * | 2018-09-20 | 2020-10-30 | 华中农业大学 | 一种杂交水牛同期发情-定时输精的处理方法 |
WO2021043726A1 (en) | 2019-09-03 | 2021-03-11 | ObsEva S.A. | Oxytocin antagonist dosing regimens for promoting embryo implantation and preventing miscarriage |
EP4103750A1 (en) | 2020-02-10 | 2022-12-21 | ObsEva S.A. | Biomarkers for oxytocin receptor antagonist therapy |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
US5705478A (en) * | 1989-02-21 | 1998-01-06 | Washington University | Covalently linked β subunits of the glycoprotein hormones as antagonists |
EP0994718B1 (en) | 1997-06-20 | 2005-08-17 | Akzo Nobel N.V. | Gonadotropin releasing hormone antagonist |
ZA987497B (en) * | 1997-09-08 | 1999-02-23 | Akzo Nobel Nv | Expression of gonadotropins in dictyostelium |
US6090848A (en) * | 1997-12-01 | 2000-07-18 | Sigma-Tau Healthscience S.P.A. | Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
BR0008468A (pt) * | 1999-02-24 | 2002-02-05 | Novo Nordisk As | Método para fertilização humana in vitro, uso de um hormÈnio hipotalânico e/ou hormÈnio pituitário ou de um agonista ou antagonista do mesmo ou de um derivado ativo do mesmo, kit farmacêutico em forma de dosagem única, e, qualquer novo aspecto ou combinação de aspectos |
ATE332705T1 (de) * | 1999-05-07 | 2006-08-15 | Applied Research Systems | Verwendung von in der mittlere oder späte follikuläre phase verabreichte lh zur behandlung von anovulatorischen frauen |
BR0107881A (pt) * | 2000-01-27 | 2003-04-01 | Applied Research Systems | Uso de fsh tratamento de infertilidade |
-
2002
- 2002-09-12 PL PL02369098A patent/PL369098A1/xx unknown
- 2002-09-12 BR BR0212429-7A patent/BR0212429A/pt not_active IP Right Cessation
- 2002-09-12 MX MXPA04002256A patent/MXPA04002256A/es not_active Application Discontinuation
- 2002-09-12 AR ARP020103456A patent/AR036592A1/es unknown
- 2002-09-12 EA EA200400427A patent/EA009330B1/ru not_active IP Right Cessation
- 2002-09-12 WO PCT/GB2002/004158 patent/WO2003022302A2/en not_active Application Discontinuation
- 2002-09-12 CN CNB028175735A patent/CN100536912C/zh not_active Expired - Fee Related
- 2002-09-12 CA CA002457849A patent/CA2457849A1/en not_active Abandoned
- 2002-09-12 EP EP02758598A patent/EP1425032A2/en not_active Withdrawn
- 2002-09-12 KR KR10-2004-7002590A patent/KR20040032954A/ko not_active Application Discontinuation
- 2002-09-12 IL IL16078002A patent/IL160780A0/xx unknown
- 2002-09-12 RS YU21004A patent/RS21004A/sr unknown
- 2002-09-12 US US10/489,220 patent/US7405197B2/en not_active Expired - Fee Related
- 2002-09-12 ME MEP-392/08A patent/MEP39208A/xx unknown
- 2002-09-12 JP JP2003526430A patent/JP2005501918A/ja active Pending
- 2002-12-09 UA UA2004031860A patent/UA82650C2/ru unknown
-
2004
- 2004-01-28 HR HRP20040087 patent/HRP20040087A2/xx not_active Application Discontinuation
- 2004-02-02 ZA ZA2004/00835A patent/ZA200400835B/en unknown
- 2004-03-08 NO NO20040991A patent/NO20040991L/no not_active Application Discontinuation
-
2005
- 2005-02-22 HK HK05101454.2A patent/HK1067867A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AR036592A1 (es) | 2004-09-22 |
JP2005501918A (ja) | 2005-01-20 |
BR0212429A (pt) | 2004-10-26 |
CN1553808A (zh) | 2004-12-08 |
PL369098A1 (en) | 2005-04-18 |
HRP20040087A2 (en) | 2004-12-31 |
HK1067867A1 (en) | 2005-04-22 |
UA82650C2 (ru) | 2008-05-12 |
MXPA04002256A (es) | 2004-07-23 |
US7405197B2 (en) | 2008-07-29 |
EA009330B1 (ru) | 2007-12-28 |
MEP39208A (en) | 2011-02-10 |
CA2457849A1 (en) | 2003-03-20 |
ZA200400835B (en) | 2005-04-26 |
NO20040991L (no) | 2004-03-08 |
RS21004A (en) | 2006-12-15 |
KR20040032954A (ko) | 2004-04-17 |
US20050065069A1 (en) | 2005-03-24 |
CN100536912C (zh) | 2009-09-09 |
WO2003022302A2 (en) | 2003-03-20 |
WO2003022302A3 (en) | 2003-12-18 |
IL160780A0 (en) | 2004-08-31 |
EP1425032A2 (en) | 2004-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200400427A1 (ru) | Применение человеческого хорионического гонадотропина и лютеинизирующего гормона при контролируемой гиперстимуляции яичников | |
DE69823046D1 (de) | Praktische in vitro sialylierung von rekombinanten glykpproteinen | |
EA200200755A1 (ru) | Опосредованная рецептором nogo блокада роста аксонов | |
BR9713294A (pt) | "anticorpos contra proteìna relacionada a hormÈnio de paratiróide humano" | |
ATE83374T1 (de) | Neue galenische form von fenofibrat. | |
CY1105616T1 (el) | ΠΕΠΤΙΔΙΑ ΑΝΑΣΤΟΛΕΙΣ ΤΟΥ TGFβ1 | |
CY1111291T1 (el) | Υγρα ή αποξηραμενα με παγο φαρμακευτικα σκευασματα fsh και/ή lh μαζι με τον mh-iontiko επιφανειοδραστικο παραγοντα poloxamer 188 και εναν βακτηριοστατικο παραγοντα | |
EA200000310A1 (ru) | April - новый белок, воздействующий на рост | |
PT944396E (pt) | Composicoes e processos para melhorar o funcionamento gastrointestinal | |
IL159177A0 (en) | Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof | |
ES2162917T3 (es) | Mejoras en o relativas al suministro de peptidos. | |
CY1110991T1 (el) | Χρηση των hcg και lh στην ελεγχομενη διεγερση των ωοθηκων | |
CY1110487T1 (el) | Χρηση της lh σε ελεγχομενη υπερδιεγερση των ωοθηκων | |
BR9509172A (pt) | Proteina de via de complemento nativa sequéncia de dna construção de dna conjugado uso de uma proteína processo para reduzir proteina de via de complemento em um mamifero e formulação farmacéutica | |
WO2002097044A3 (en) | Alternative splice forms of proteins as basis for multiple therapeutic modalities | |
DE60335726D1 (de) | Chromoprotein und fluoroproteine | |
IL145689A0 (en) | Methods | |
ES2042461T1 (es) | Producto y procedimiento para el te\ido oxidativo del cabello. | |
BR0211951A (pt) | Farinha de glúten de proteìna branca e métodos de uso | |
ECSP034743A (es) | Peptidos a partir del anticuerpo 16/61d para tratar lupus eritematoso sistemico | |
ATE397081T1 (de) | Erhöhte expression von proteinen mittels gfp | |
ATE355302T1 (de) | N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation | |
ATE500790T1 (de) | Knochennagel zum versorgen von frakturen | |
NO971508L (no) | Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet | |
ES2185652T3 (es) | Oligopeptidos derivados de fragmentos de proteinas c-reactiva. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC4A | Registration of transfer of a eurasian patent by assignment | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
PD4A | Registration of transfer of a eurasian patent in accordance with the succession in title | ||
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |